241 related articles for article (PubMed ID: 28453748)
1. Incidence of pseudoprogression in low-grade gliomas treated with radiotherapy.
van West SE; de Bruin HG; van de Langerijt B; Swaak-Kragten AT; van den Bent MJ; Taal W
Neuro Oncol; 2017 May; 19(5):719-725. PubMed ID: 28453748
[TBL] [Abstract][Full Text] [Related]
2. Pseudoprogression Is Frequent After Front-Line Radiation Therapy in Pediatric Low-Grade Glioma: Results From the German Low-Grade Glioma Cohort.
Stock A; Hancken CV; Kandels D; Kortmann RD; Dietzsch S; Timmermann B; Pietsch T; Bison B; Schmidt R; Pham M; Gnekow AK; Warmuth-Metz M
Int J Radiat Oncol Biol Phys; 2022 Apr; 112(5):1190-1202. PubMed ID: 34933039
[TBL] [Abstract][Full Text] [Related]
3. Increased risk of pseudoprogression among pediatric low-grade glioma patients treated with proton versus photon radiotherapy.
Ludmir EB; Mahajan A; Paulino AC; Jones JY; Ketonen LM; Su JM; Grosshans DR; McAleer MF; McGovern SL; Lassen-Ramshad YA; Adesina AM; Dauser RC; Weinberg JS; Chintagumpala MM
Neuro Oncol; 2019 May; 21(5):686-695. PubMed ID: 30753704
[TBL] [Abstract][Full Text] [Related]
4. Pseudoprogression of low-grade gliomas after radiotherapy.
Naftel RP; Pollack IF; Zuccoli G; Deutsch M; Jakacki RI
Pediatr Blood Cancer; 2015 Jan; 62(1):35-9. PubMed ID: 25213668
[TBL] [Abstract][Full Text] [Related]
5. Early and late contrast enhancing lesions after photon radiotherapy for IDH mutated grade 2 diffuse glioma.
Jaspers JPM; Taal W; van Norden Y; Zindler JD; Swaak AT; Habraken SJM; Hoogeman MS; Nout R; van den Bent MJ; Méndèz Romero A
Radiother Oncol; 2023 Jul; 184():109674. PubMed ID: 37084885
[TBL] [Abstract][Full Text] [Related]
6. MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients.
Brandes AA; Franceschi E; Tosoni A; Blatt V; Pession A; Tallini G; Bertorelle R; Bartolini S; Calbucci F; Andreoli A; Frezza G; Leonardi M; Spagnolli F; Ermani M
J Clin Oncol; 2008 May; 26(13):2192-7. PubMed ID: 18445844
[TBL] [Abstract][Full Text] [Related]
7. Pseudoprogression in pediatric low-grade glioma after irradiation.
Tsang DS; Murphy ES; Lucas JT; Lagiou P; Acharya S; Merchant TE
J Neurooncol; 2017 Nov; 135(2):371-379. PubMed ID: 28752498
[TBL] [Abstract][Full Text] [Related]
8. Pseudoprogression in patients with malignant gliomas treated with concurrent temozolomide and radiotherapy: potential role of p53.
Kang HC; Kim CY; Han JH; Choe GY; Kim JH; Kim JH; Kim IA
J Neurooncol; 2011 Mar; 102(1):157-62. PubMed ID: 20632071
[TBL] [Abstract][Full Text] [Related]
9. Cognitive and radiological effects of radiotherapy in patients with low-grade glioma: long-term follow-up.
Douw L; Klein M; Fagel SS; van den Heuvel J; Taphoorn MJ; Aaronson NK; Postma TJ; Vandertop WP; Mooij JJ; Boerman RH; Beute GN; Sluimer JD; Slotman BJ; Reijneveld JC; Heimans JJ
Lancet Neurol; 2009 Sep; 8(9):810-8. PubMed ID: 19665931
[TBL] [Abstract][Full Text] [Related]
10. Increase of pseudoprogression and other treatment related effects in low-grade glioma patients treated with proton radiation and temozolomide.
Dworkin M; Mehan W; Niemierko A; Kamran SC; Lamba N; Dietrich J; Martinez-Lage M; Oh KS; Batchelor TT; Wen PY; Loeffler JS; Shih HA
J Neurooncol; 2019 Mar; 142(1):69-77. PubMed ID: 30488294
[TBL] [Abstract][Full Text] [Related]
11. Pseudoprogression after radiotherapy with concurrent temozolomide for high-grade glioma: clinical observations and working recommendations.
Chaskis C; Neyns B; Michotte A; De Ridder M; Everaert H
Surg Neurol; 2009 Oct; 72(4):423-8. PubMed ID: 19150114
[TBL] [Abstract][Full Text] [Related]
12. Early post-treatment pseudo-progression amongst glioblastoma multiforme patients treated with radiotherapy and temozolomide: a retrospective analysis.
Gunjur A; Lau E; Taouk Y; Ryan G
J Med Imaging Radiat Oncol; 2011 Dec; 55(6):603-10. PubMed ID: 22141608
[TBL] [Abstract][Full Text] [Related]
13. Neuroendocrine late effects after tailored photon radiotherapy for children with low grade gliomas: Long term correlation with tumour and treatment parameters.
Aloi D; Belgioia L; Barra S; Giannelli F; Cavagnetto F; Gallo F; Milanaccio C; Garrè M; Di Profio S; Di Iorgi N; Corvò R
Radiother Oncol; 2017 Nov; 125(2):241-247. PubMed ID: 29037775
[TBL] [Abstract][Full Text] [Related]
14. Late Effects After Radiotherapy for Childhood Low-grade Glioma.
Williams NL; Rotondo RL; Bradley JA; Pincus DW; Fort JA; Wynn T; Morris CG; Mendenhall NP; Indelicato DJ
Am J Clin Oncol; 2018 Mar; 41(3):307-312. PubMed ID: 26808258
[TBL] [Abstract][Full Text] [Related]
15. Bevacizumab for symptomatic radiation-induced tumor enlargement in pediatric low grade gliomas.
Foster KA; Ares WJ; Pollack IF; Jakacki RI
Pediatr Blood Cancer; 2015 Feb; 62(2):240-245. PubMed ID: 25382690
[TBL] [Abstract][Full Text] [Related]
16. First experiences in treatment of low-grade glioma grade I and II with proton therapy.
Hauswald H; Rieken S; Ecker S; Kessel KA; Herfarth K; Debus J; Combs SE
Radiat Oncol; 2012 Nov; 7():189. PubMed ID: 23140402
[TBL] [Abstract][Full Text] [Related]
17. Characterization of pseudoprogression in patients with glioblastoma: is histology the gold standard?
Melguizo-Gavilanes I; Bruner JM; Guha-Thakurta N; Hess KR; Puduvalli VK
J Neurooncol; 2015 May; 123(1):141-50. PubMed ID: 25894594
[TBL] [Abstract][Full Text] [Related]
18. Rescue bevacizumab following symptomatic pseudoprogression of a tectal glioma post-radiotherapy: a case report and review of the literature.
Nguyen TK; Perry J; Sundaram ANE; Detsky J; Maralani PJ; Calabrese E; Das S; Sahgal A
J Neurooncol; 2019 Jul; 143(3):475-481. PubMed ID: 31054097
[TBL] [Abstract][Full Text] [Related]
19. Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas.
Brandsma D; Stalpers L; Taal W; Sminia P; van den Bent MJ
Lancet Oncol; 2008 May; 9(5):453-61. PubMed ID: 18452856
[TBL] [Abstract][Full Text] [Related]
20. Recurrent low-grade gliomas: the role of fractionated stereotactic re-irradiation.
Combs SE; Ahmadi R; Schulz-Ertner D; Thilmann C; Debus J
J Neurooncol; 2005 Feb; 71(3):319-23. PubMed ID: 15735924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
